Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The myeloid disorders: background.

John Swansbury1

  • 1Academic Haematology and Cytogenetics, The Royal Marsden NHS Trust, The Institute of Cancer Research, Surrey, UK.

Methods in Molecular Biology (Clifton, N.J.)
|May 15, 2003
PubMed
Summary

Cytogenetic analysis in myeloid disorders presents fewer technical challenges than acute lymphoblastic leukemia (ALL). However, detecting specific chromosomal abnormalities remains difficult for many patients, limiting diagnostic and prognostic insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.

European journal of cancer (Oxford, England : 1990)·2019
Same author

Desmoplastic small round cell tumor: evaluation of reverse transcription-polymerase chain reaction and fluorescence in situ hybridization as ancillary molecular diagnostic techniques.

Virchows Archiv : an international journal of pathology·2017
Same author

The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.

British journal of cancer·2017
Same author

Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.

Methods in molecular biology (Clifton, N.J.)·2016
Same author

The distinctive micromegakaryocytes of transformed chronic myeloid leukemia.

American journal of hematology·2016
Same author

Ancillary molecular analysis in the diagnosis of soft tissue tumours: reassessment of its utility at a specialist centre.

Journal of clinical pathology·2015

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • Myeloid disorders often present fewer technical challenges for cytogenetic analysis compared to acute lymphoblastic leukemia (ALL).
  • Unlike chronic lymphoid disorders, myeloid disorders do not typically require mitogens for cell division.
  • Except for chronic granulocytic leukemia (CGL), the frequency of detectable cytogenetic clones in myeloid disorders is generally low.

Purpose of the Study:

  • To highlight the challenges in cytogenetic analysis for myeloid disorders.
  • To emphasize the diagnostic and prognostic benefits of identifying cytogenetic abnormalities.
  • To address the low frequency of detected clones in myeloid disorders, apart from CGL.

Main Methods:

  • Cytogenetic analysis of myeloid disorder patient samples.
  • Comparison of technical challenges with ALL and chronic lymphoid disorders.
  • Evaluation of the frequency of detected cytogenetic clones.

Main Results:

  • Cytogenetic analysis in myeloid disorders is technically less demanding than in ALL.
  • The Philadelphia chromosome (Ph) in CGL is a notable exception to lower clone detection rates.
  • A significant proportion of myeloid disorder patients do not benefit from cytogenetic abnormality detection.

Conclusions:

  • Despite technical advantages, identifying cytogenetic abnormalities in myeloid disorders remains a challenge.
  • The limited detection rate of clones denies many patients crucial diagnostic and prognostic information.
  • Further research is needed to improve the detection and utility of cytogenetic analysis in myeloid disorders.

Related Experiment Videos